Paper - WANFANG MED ONLINE

You Position: Home > Paper

Advances in the pathogenesis and treatment of acne inversa

( views:311, downloads:340 )

Author:: No author available

Journal Title:: INTERNATIONAL JOURNAL OF DERMATOLOGY AND VENEREOLOGY

Issue:: 4

DOI:: 10.3760/cma.j.issn.1673-4173.2011.04.017

Key Word:: 汗腺炎,化脓性;遗传;治疗;Hidradenitis suppurativa;Heredity;Therapy

Abstract： Acne inversa (AI) is a kind of chronic recúrrent inflammatory disease.Females are more likely to be affected by AI than males.Apocrine gland-bearing areas including axillary,inguinal,perianal,and perineal regions are commonly involved.The etiology of AI is unknown,and may be associated with genetic factors,hair follicular changes,bacterial infection,immunological factors,sexual hormones,smoking and obesity.Treatment includes antibiotics,retinoids,sexual hormones,tumor necrosis factor-alpha inhibitors,laser and surgery.This article presents the advances in the pathogenesis and treatment of AI,which may benefit its prevention and control.

Reference

[1]Fiedler E,Stadie V,Wohlrab J,etc.Hidradenitis suppurativa (acne inversa): early inflammatory events at terminal follicles and at interfollicular epidermis.[J].2010,19(6).
[2]Hunger RE,Surovy AM,Hassan AS,etc.Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor.[J].2008,158(4).
[3]Al Ali MT,Mehta TY,Naveed M,etc.Hidradenitis suppurativa (or Acne inversa) with autosomal dominant inheritance is not linked to chromosome 1p21.1-1q25.3 region.[J].2010,19(9).
[4]Victor M. Martinez Taboada,Ignacio Villa,Ricardo Blanco.Long-term Successful Adalimumab Therapy in Severe Hidradenitis Suppurativa[J].2009,145(5).
[5]D E M, Slade,B W, Powell,P S, Mortimer.Hidradenitis suppurativa: pathogenesis and management.[J].2003,56(5).
[6]Prens EP,Boer J,van der Zee HH.The effect of combined treatment with oral clindamycin and oral rifampicin in patients with hidradenitis suppurativa.[J].2009,219(2).
[7]Sellheyer K,Krahl D."Hidradenitis suppurativa" is acne inversa! An appeal to (finally) abandon a misnomer.[J].2005,44(7).
[8]Hazen BP,Hazen PG.Hidradenitis suppurativa: successful treatment using carbon dioxide laser excision and marsupialization.[J].2010,36(2).
[9]Passeron T,Khemis A,Ortonne JP.Pulsed dye laser-mediated photodynamic therapy for acne inversa is not successful: a pilot study on four cases.[J].2009,20(5).
[10]Sartorius K,Emtestam L,Jemec GB.Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity.[J].2009,161(4).
[11]Arenberger P,Gkalpakiotis S,Arenbergerova M.Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy.[J].2010,49(12).
[12]Baoxi, Wang,Wei, Yang,Wen, Wen,etc.Gamma-secretase gene mutations in familial acne inversa.[J].2010,330(6007).
[13]Lee RA,Dommasch E,Treat J.A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa.[J].2009,60(4).
[14]Matusiak L,Bieniek A,Szepietowski JC.Hidradenitis suppurativa and associated factors: still unsolved problems.[J].2009,61(2).
[15]Grant A,Gonzalez T,Montgomery M.Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: a randomized, double-blind, placebo-controlled crossover trial.[J].2010,62(2).
[16]Soria A,Canoui-Poitrine F,Wolkenstein P,etc.Absence of efficacy of oral isotretinoin in hidradenitis suppurativa: a retrospective study based on patients' outcome assessment.[J].2009,218(2).
[17]Nassif A,Coignard H,Berche P,etc.Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa.[J].2011,222(1).
[18]Mahmoud BH,Tierney E,Hexsel CL,etc.Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser.[J].2010,62(4).
[19]Bieniek A,Matusiak L,Okulewicz Gojlik D,etc.Surgical treatment of hidradenitis suppurativa: experiences and recommendations.[J].2010,36(12).
[20]Massone C,Brunasso AM.Rotational therapy with TNF-alpha blockers for recalcitrant hidradenitis suppurativa.[J].2010,20(5).
[21]David R. Adams,Jessica A. Yankura,Anneli C. Fogelberg.Treatment of Hidradenitis Suppurativa With Etanercept Injection[J].2010,146(5).
[22]Wolkenstein P,Canoui Poitrine F,Revuz JE.Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.[J].2009,61(1).
[23]von Laffert M,Stadie V,Wohlrab J,etc.Hidradenitis suppurativa/acne inversa: bilocated epithelial hyperplasia with very different sequelae.[J].2011,164(2).
[24]Adnan, Menderes,Ozgur, Sunay,Haluk, Vayvada,etc.Surgical management of hidradenitis suppurativa.[J].2010,7(4).
[25]Schlapbach C,Yawalkar N,Hunger RE.Human beta-defensin-2 and psoriasin are overexpressed in lesions of acne inversa.[J].2009,61(1).
[26]Varkarakis G,Daniels J,Coker K,etc.Treatment of axillary hidradenitis with transposition flaps: a 6-year experience.[J].2010,64(5).
[27]Gener G,Canoui Poitrine F,Revuz JE.Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.[J].2009,219(2).
[28]Eisen DB,Alikhan A,Lynch PJ.Hidradenitis suppurativa: a comprehensive review.[J].2009,60(4).
[29]Pelekanou E,Antonopoulou A,Petropoulou H,etc.An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa.[J].2008,158(3).